Expert pathologists and a medical oncologist will discuss current guidelines and their own practices regarding the role of liquid biopsy and comprehensive genetic and PD-L1 testing in the management of advanced lung cancer. The panelists will discuss the various strategies for optimizing the quantity and quality of cytology and small volume biopsy specimens. This interactive webinar will offer the opportunity for learners to ask questions prior to and during the event. Learning is augmented by a few follow-up quizzes weeks after the webinar, a strategy proven to improve knowledge gain and retention.
- Provider:American College of Chest Physicians
- Activity Link: https://www.chestnet.org/Education/Library/elearning
- Start Date: 2022-05-10 05:00:00
- End Date: 2022-05-10 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.25 hours
- MOC Credit Details: ABIM - 1.25 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: AstraZeneca (Any division) - Amount: 200000.0 - Is Kind Support: False Source: Genentech (Any division) - Amount: 200000.0 - Is Kind Support: False Source: Merck (Any division) - Amount: 40000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Competence, Learner Knowledge
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Medical Oncology, Pulmonary Disease
Subscribe
Login
0 Comments
Oldest